Ephedrine
Also known as: Ephedrine, Ephedrin, Ephedrine HCl, Ma Huang, Ephedra
The original fat burner, with a real and measured effect — and the reason the ECA stack was banned is not that it did not work.
Substance family
They increase metabolic rate or mobilise fat through adrenergic and thermogenic mechanisms. Cardiac load is the shared limiting factor, and it adds up when they are combined.
Effects on
Which outcomes this substance acts on — descriptive, not a recommendation.
Strain profile
Where this substance is most likely to hit — a rough orientation, individually dependent on dose, duration and predisposition.
Dosing & protocols by goal
Rough orientation ranges as reported in harm-reduction literature — not an individual treatment plan. Doses are individual and open-ended; frequency depends on the ester or half-life.
ECA stack (the classic combination)
AdvancedDose
20 mg ephedrine + 200 mg caffeine
Frequency
2–3× / day, last dose before 4 pm
Cycle length
In blocks, with breaks
Aspirin was the third component in the original stack and is largely dropped now — the evidence for its contribution was weak and it adds bleeding risk. Caffeine is the part that genuinely potentiates the effect.
Starting point
IntermediateDose
8–10 mg ephedrine
Frequency
1× to assess tolerance
Cycle length
—
TitrationTitrationAdjusting a dose stepwise against a measured result rather than setting it in advance. matters here. A first dose at 25 mg reliably produces tremor, palpitations and anxiety, and the cardiovascular response varies substantially between people.
Higher doses
Not a recommendationDose
> 60 mg / day
Frequency
—
Cycle length
—
The thermogenic effect plateaus while the cardiovascular load does not. The deaths associated with ephedra supplements occurred in this territory, frequently combined with dehydration or exertion in heat.
Side effect & countermeasure
Typical problems and what you can do to reduce harm — at a glance. Does not replace medical monitoring.
Problem
Cardiovascular strain
Countermeasure
Ephedrine raises heart rate and blood pressure through direct adrenergic stimulation. Measure both rather than judging by feel; palpitations, chest tightness or an irregular pulse mean stop. Pre-existing hypertension, arrhythmia or cardiac disease rule it out, and that includes the elevated blood pressure most people carry on cycle.
Problem
Stacking with other stimulants
Countermeasure
Clenbuterol, yohimbine and high-dose caffeine all drive the same system. Combining them multiplies the cardiac load rather than adding to it. Ephedrine plus clenbuterol is a particularly poor idea, and either alongside a diuretic in contest week is the arrhythmia scenario behind documented deaths.
Problem
Tolerance builds quickly
Countermeasure
The thermogenic effect fades within a few weeks as receptors desensitise. Raising the dose restores little and increases the cardiovascular risk. Cycling it in blocks is the standard response.
Problem
Insomnia and anxiety
Countermeasure
With a half-lifehalf-lifeHow long it takes for half the substance to leave the body — it determines dosing frequency, not duration of effect. of three to six hours, an afternoon dose still acts at night. Nothing after 4 pm. Poor sleep undermines the deficit the stimulant is meant to support, and it raises cortisol against you.
Problem
The ephedra ban had real reasons
Countermeasure
Ephedra supplements were banned in the US after deaths and serious cardiovascular events, including in young, apparently healthy users. Those cases typically involved high doses, other stimulants, dehydration or exertion in heat. The compound is not uniquely lethal at controlled doses — but the ban was not regulatory overreach either.
Overview
Ephedrine is the original evidence-based fat burner, and unusually for this category, the evidence is good. The ECA stack — ephedrine, caffeine, aspirin — was studied properly in the 1990s and produced measurable fat loss beyond diet alone.
That is the honest starting point. What followed was a wave of high-dose supplements, serious cardiovascular events, and a US ban in 2004 that reshaped the whole supplement industry.
Mechanism of Action
Ephedrine is a sympathomimetic: it stimulates alpha- and beta-adrenergic receptors directly and also promotes noradrenaline release. The result is the classic adrenergic picture — higher heart rate, higher blood pressure, raised metabolic rate, suppressed appetite and increased fat mobilisation.
Caffeine potentiates this by blocking the enzyme that would break down the intracellular signal, which is why the combination works better than either alone. That synergy is real and is the reason the stack exists.
The thermogenic effect is measurable but modest — a few percent of daily energy expenditure, in the same range as clenbuterol. It does not replace a deficit.
Where It Sits Against Clenbuterol
Both are adrenergic, both raise metabolic rate modestly, both strain the heart.
Ephedrine has the shorter half-life at three to six hours against clenbuterol's day-plus, which makes it easier to control and easier to keep out of the evening. It also has actual human trial data, which clenbuterol largely lacks outside its respiratory indication.
Clenbuterol is more beta-2 selective, so the cardiac effect is somewhat less direct — though at the doses used, that distinction is thinner than it sounds.
Neither is a large effect. Both carry a real cardiovascular cost.
The Aspirin Question
The original stack included aspirin, on the reasoning that it would prolong the thermogenic response.
Most people have dropped it, and that is reasonable: the evidence for its contribution was weak, and daily aspirin carries a bleeding risk that is not worth taking for a marginal effect. If aspirin is being taken for cardiovascular reasons, that is a separate decision with its own logic.
Side Effects & Risks
- Elevated heart rate and blood pressure
- Palpitations, arrhythmia at higher doses
- Anxiety, restlessness, tremor
- Insomnia
- Dry mouth, nausea
- Rapid tolerance
- Serious cardiovascular events, particularly with high doses, stimulant stacking, dehydration or heat
Blood Work & Monitoring
- Blood pressure and resting heart rate — measured daily, not estimated; this is the main safety metric
- Potassium — if a diuretic is anywhere in the picture
- General panel if used repeatedly over longer periods
Legal status by region
Regulation differs considerably between jurisdictions and changes over time. This is a rough orientation, not legal advice — check the rules that apply where you are.
| Region | Regulatory status |
|---|---|
| United States | Banned as a dietary supplement; pharmacy-restricted as a medicineThe FDA banned ephedra supplements in 2004. Pseudoephedrine and ephedrine sales are tracked because of methamphetamine synthesis. |
| EU / UK | Prescription or pharmacy medicineNot permitted as a food supplement. |
| Most other jurisdictions | Restricted; availability varies widely |
| Competitive sport | Prohibited in competitionWADA S6 stimulants, above a urinary threshold. |